This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montoya, J. G.
Right arrow Articles by Remington, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montoya, J. G.
Right arrow Articles by Remington, J. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2002, p. 2504-2508, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2504-2508.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

VIDAS Test for Avidity of Toxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women

Jose G. Montoya,1,2* Oliver Liesenfeld,1,{dagger} Sandra Kinney,1 Cynthia Press,1 and Jack S. Remington1,2

Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto,1 Department of Medicine and Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California2

Received 30 January 2002/ Returned for modification 3 April 2002/ Accepted 25 April 2002

Because congenital toxoplasmosis is almost solely the result of maternal infection acquired during gestation, it is critical to determine whether infection during pregnancy has occurred. In the United States, definitive diagnosis of the acute infection and the time of its occurrence have been compromised by a lack of systematic screening and the fact that only a single serum sample is submitted for testing. In studies in Europe, and depending on the method used, the demonstration of high-avidity immunoglobulin G (IgG) toxoplasma antibodies has been shown to exclude infection having occurred in the first 3 to 5 months of pregnancy. We investigated the usefulness of determining the avidity of IgG toxoplasma antibodies with a VIDAS kit (herein referred to as the VIDAS Toxo-IgG avidity kit, the VIDAS kit essentially rules out acute infection having occurred within the 4 prior months) in the setting of a reference serology laboratory in the United States. Sera (132 samples) from 132 women in the first 16 weeks of pregnancy were chosen because at least one test in the toxoplasma serological profile (TSP) suggested or was equivocal for a recently acquired infection. High-avidity antibodies were demonstrated in 75% of 99 sera positive with the IgM enzyme-linked immunosorbent assay (ELISA) and 31.3% of 16 sera with acute TSP results. A significant percentage of sera with equivocal results wtih the IgM ELISA or TSP also had high-avidity test results. Of 39 women for whom treatment with spiramycin had been suggested to attempt to prevent congenital transmission, 19 (48.7%) had high-avidity antibodies. These findings highlight the value of the VIDAS IgG avidity kit when used in combination with the TSP to exclude recent infection, especially when only a single serum sample is available.

* Corresponding author. Mailing address: Research Institute, Palo Alto Medical Foundation, Ames Building, 795 El Camino Real, Palo Alto, CA 94301. Phone: (650) 853-6061. Fax: (650) 329-9853. E-mail: gilberto{at}leland.stanford.edu.

{dagger} Present address: Department of Medical Microbiology and Immunology of Infection, Institute for Infection Medicine, Benjamin Franklin Medical Center, Free University of Berlin, Berlin, Germany.

Journal of Clinical Microbiology, July 2002, p. 2504-2508, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2504-2508.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Meroni, V., Genco, F., Tinelli, C., Lanzarini, P., Bollani, L., Stronati, M., Petersen, E. (2009). Spiramycin Treatment of Toxoplasma gondii Infection in Pregnant Women Impairs the Production and the Avidity Maturation of T. gondii-Specific Immunoglobulin G Antibodies. CVI 16: 1517-1520 [Abstract] [Full Text]  
  • Curdt, I., Praast, G., Sickinger, E., Schultess, J., Herold, I., Braun, H. B., Bernhardt, S., Maine, G. T., Smith, D. D., Hsu, S., Christ, H. M., Pucci, D., Hausmann, M., Herzogenrath, J. (2009). Development of Fully Automated Determination of Marker-Specific Immunoglobulin G (IgG) Avidity Based on the Avidity Competition Assay Format: Application for Abbott Architect Cytomegalovirus and Toxo IgG Avidity Assays. J. Clin. Microbiol. 47: 603-613 [Abstract] [Full Text]  
  • Iqbal, J., Khalid, N. (2007). Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. J Med Microbiol 56: 1495-1499 [Abstract] [Full Text]  
  • Press, C., Montoya, J. G., Remington, J. S. (2005). Use of a Single Serum Sample for Diagnosis of Acute Toxoplasmosis in Pregnant Women and Other Adults. J. Clin. Microbiol. 43: 3481-3483 [Abstract] [Full Text]  
  • Petersen, E., Borobio, M. V., Guy, E., Liesenfeld, O., Meroni, V., Naessens, A., Spranzi, E., Thulliez, P. (2005). European Multicenter Study of the LIAISON Automated Diagnostic System for Determination of Toxoplasma gondii-Specific Immunoglobulin G (IgG) and IgM and the IgG Avidity Index. J. Clin. Microbiol. 43: 1570-1574 [Abstract] [Full Text]  
  • Kaul, R., Chen, P., Binder, S. R. (2004). Detection of Immunoglobulin M Antibodies Specific for Toxoplasma gondii with Increased Selectivity for Recently Acquired Infections. J. Clin. Microbiol. 42: 5705-5709 [Abstract] [Full Text]  
  • Montoya, J. G., Huffman, H. B., Remington, J. S. (2004). Evaluation of the Immunoglobulin G Avidity Test for Diagnosis of Toxoplasmic Lymphadenopathy. J. Clin. Microbiol. 42: 4627-4631 [Abstract] [Full Text]  
  • Flori, P., Tardy, L., Patural, H., Bellete, B., Varlet, M.-N., Hafid, J., Raberin, H., Sung, R. T. M. (2004). Reliability of Immunoglobulin G Antitoxoplasma Avidity Test and Effects of Treatment on Avidity Indexes of Infants and Pregnant Women. CVI 11: 669-674 [Abstract] [Full Text]  
  • Pannuti, C. S., Morello, R. J., de Moraes, J. C., Curti, S. P., Afonso, A. M. S., Camargo, M. C. C., de Souza, V. A. U. F. (2004). Identification of Primary and Secondary Measles Vaccine Failures by Measurement of Immunoglobulin G Avidity in Measles Cases during the 1997 Sao Paulo Epidemic. CVI 11: 119-122 [Abstract] [Full Text]  
  • Beghetto, E., Buffolano, W., Spadoni, A., Del Pezzo, M., Di Cristina, M., Minenkova, O., Petersen, E., Felici, F., Gargano, N. (2003). Use of an Immunoglobulin G Avidity Assay Based on Recombinant Antigens for Diagnosis of Primary Toxoplasma gondii Infection during Pregnancy. J. Clin. Microbiol. 41: 5414-5418 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»